TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.
The NOR-TEST 2A trial was stopped after increased rates of ICH and mortality were seen in the group assigned to tenecteplase 0.4 mg/kg compared with the standard dose of alteplase.
The use of aspirin or heparin during treatment of acute ischemic stroke was associated with an increased risk of intracranial hemorrhage without evidence for a beneficial effect on functional outcome.